Free Trial

BKV Corporation (NYSE:BKV) Insider Sells $216,200.00 in Stock

BKV logo with Energy background

Key Points

  • BKV Corporation insider Lindsay B. Larrick sold 10,000 shares for $216,200, representing a 4.75% decrease in their ownership stake.
  • The company's stock recently traded at $21.23, with an average price target of $28.25 from analysts, indicating a generally positive outlook.
  • BKV reported earnings of $0.39 EPS, exceeding expectations and suggesting strong quarterly performance compared to the consensus estimate of $0.24 EPS.
  • Need better tools to track BKV? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

BKV Corporation (NYSE:BKV - Get Free Report) insider Lindsay B. Larrick sold 10,000 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $21.62, for a total value of $216,200.00. Following the sale, the insider directly owned 200,528 shares in the company, valued at $4,335,415.36. This trade represents a 4.75% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

BKV Stock Performance

Shares of BKV stock traded up $1.17 during trading on Tuesday, reaching $21.23. The company's stock had a trading volume of 471,671 shares, compared to its average volume of 425,530. The company has a 50-day simple moving average of $22.15 and a two-hundred day simple moving average of $21.18. BKV Corporation has a 1-year low of $15.00 and a 1-year high of $26.78. The company has a quick ratio of 0.39, a current ratio of 0.41 and a debt-to-equity ratio of 0.13.

BKV (NYSE:BKV - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.15. On average, sell-side analysts predict that BKV Corporation will post -1.82 EPS for the current fiscal year.

Institutional Trading of BKV

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC purchased a new position in shares of BKV during the 4th quarter valued at about $7,728,000. Driehaus Capital Management LLC purchased a new position in shares of BKV in the 4th quarter valued at about $9,553,000. California State Teachers Retirement System purchased a new position in shares of BKV in the 4th quarter valued at about $26,000. Corebridge Financial Inc. purchased a new stake in BKV during the 4th quarter worth approximately $170,000. Finally, Bank of New York Mellon Corp increased its stake in BKV by 21.2% during the 1st quarter. Bank of New York Mellon Corp now owns 35,453 shares of the company's stock worth $745,000 after buying an additional 6,209 shares in the last quarter.

Wall Street Analyst Weigh In

Several brokerages have issued reports on BKV. Barclays increased their target price on BKV from $29.00 to $30.00 and gave the company an "overweight" rating in a research report on Monday, July 7th. Evercore ISI raised their price objective on BKV from $20.00 to $26.00 and gave the stock an "outperform" rating in a research report on Friday, May 30th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, BKV presently has an average rating of "Buy" and an average price target of $28.25.

Read Our Latest Stock Report on BKV

About BKV

(Get Free Report)

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.

Featured Articles

Insider Buying and Selling by Quarter for BKV (NYSE:BKV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BKV Right Now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines